Literature DB >> 1987276

IL-6 production by human T lymphocytes. Expression in HTLV-1-infected but not in normal T cells.

P M Villiger1, M T Cronin, T Amenomori, W Wachsman, M Lotz.   

Abstract

IL-6 is an important regulator of humoral and cellular immunity. Although this cytokine is produced by diverse cell types, it is not known whether it is produced by T lymphocytes under physiologic conditions or which agents can induce T cell expression of IL-6. We analyzed the production of IL-6 by human peripheral blood T cells, human thymocytes, and human T cell lines. In pure populations of these cells, stimulated with different combinations of various mitogens and cytokines, IL-6 activity could not be detected. Analysis of purified T-alpha beta and T-gamma delta cells showed that neither T cell subset produced IL-6. Similarly, IL-6 mRNA was not detected in T cell or thymocyte populations for up to 48 h after stimulation. With the use of a PCR assay, IL-6 mRNA in T cells was found to be virtually negligible, and did not change after T cell activation. By in situ hybridization it was shown that the cells expressing IL-6 mRNA after mitogen activation of PBMC do not belong to the T cell lineage. To analyze whether human T cells express IL-6 in vivo, we examined lymphoid tissues by in situ hybridization. In normal human thymus there was no detectable signal for IL-6. Tonsils showed only few positive cells within the parenchyma, but strong expression of IL-6 by epithelial cells in crypts. In contrast to normal lymph node, which contained only rare cells positive for IL-6, a lymph node from a patient with Castleman's disease showed IL-6 expression in cells occupying the marginal sinus and interfollicular areas. Screening of various human T cell lines showed that all cell lines infected with HTLV-1 secrete IL-6 activity and express IL-6 mRNA. In addition, in vitro infection of peripheral blood T cells with HTLV-1 induced de novo synthesis and secretion of IL-6. Furthermore, IL-6 expression in HTLV-1-infected cells was enhanced by stimulation with IL-1 beta or TNF-alpha. In contrast, IL-6 was not detectable in non-infected T cell lines. These studies indicate that IL-6 may not be a physiologic product of human T lymphocytes and that infection of T cells with HTLV-1 results in aberrant expression of this cytokine.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1987276

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  29 in total

1.  Treatment for HTLV-I associated arthropathy: a case study and synovial tissue culture analysis.

Authors:  Toshiaki Takahashi; Shigeki Takemoto; Katsuhito Kiyasu; Hiroshi Yamamoto; Toshikazu Tani; Isamu Miyoshi; Hirokuni Taguchi; Toshiaki Moriki; Emiko Miyazaki; Hideaki Enzan
Journal:  Rheumatol Int       Date:  2005-07-01       Impact factor: 2.631

2.  Cytokine production by endothelial cells infected with human T cell lymphotropic virus type I.

Authors:  H Takashima; K Eguchi; A Kawakami; Y Kawabe; K Migita; M Sakai; T Origuchi; S Nagataki
Journal:  Ann Rheum Dis       Date:  1996-09       Impact factor: 19.103

3.  Costimulation of cytokine gene expression in T cells by the human T leukemia/lymphotropic virus type 1 trans activator Tax.

Authors:  S R Himes; R Katsikeros; M F Shannon
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

4.  Infection of human synovial cells by human T cell lymphotropic virus type I. Proliferation and granulocyte/macrophage colony-stimulating factor production by synovial cells.

Authors:  M Sakai; K Eguchi; K Terada; M Nakashima; I Yamashita; H Ida; Y Kawabe; T Aoyagi; H Takino; T Nakamura
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

5.  Impaired proliferative capacity and abnormal cytokine profile of naive and memory CD4 T cells from HIV-seropositive patients.

Authors:  A Cayota; F Vuillier; D Scott-Algara; V Feuillie; G Dighiero
Journal:  Clin Exp Immunol       Date:  1992-06       Impact factor: 4.330

6.  Leukemia inhibitory factor is expressed in cartilage and synovium and can contribute to the pathogenesis of arthritis.

Authors:  M Lotz; T Moats; P M Villiger
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

7.  Expression of a protein involved in bone resorption, Dkk1, is activated by HTLV-1 bZIP factor through its activation domain.

Authors:  Nicholas Polakowski; Heather Gregory; Jean-Michel Mesnard; Isabelle Lemasson
Journal:  Retrovirology       Date:  2010-07-23       Impact factor: 4.602

8.  Baboon T cell lymphomas expressing the B cell-associated surface proteins CD40 and Bgp95.

Authors:  L V Indzhiia; L A Yakovleva; J Overbaugh; K A Licciardi; M G Chikobava; I N Klotz; R Torres; V O Indzhiia; B A Lapin; E A Clark
Journal:  J Clin Immunol       Date:  1992-05       Impact factor: 8.317

9.  Human immunodeficiency virus type 1 envelope glycoproteins gp120 and gp160 induce interleukin-6 production in CD4+ T-cell clones.

Authors:  N Oyaizu; N Chirmule; Y Ohnishi; V S Kalyanaraman; S Pahwa
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

10.  A lymphoid cell-specific nuclear factor containing c-Rel-like proteins preferentially interacts with interleukin-6 kappa B-related motifs whose activities are repressed in lymphoid cells.

Authors:  K Nakayama; H Shimizu; K Mitomo; T Watanabe; S Okamoto; K Yamamoto
Journal:  Mol Cell Biol       Date:  1992-04       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.